Insulet (PODD) Current Taxes (2011 - 2012)
Insulet (PODD) reported Current Taxes of $4.0 million for Q4 2012, up 1505.26% on a YoY basis from $247000.0 in Q1 2012, and up 1505.26% quarter-over-quarter from $247000.0 in Q4 2011.
Insulet (PODD) Current Taxes (2011 - 2012) Analysis & Trends
Insulet has reported Current Taxes for 2 years, with the latest figure at $4.0 million in Q4 2012.
- For the quarter ending Q4 2012, Current Taxes rose 1505.26% year-over-year to $4.0 million; the trailing twelve-month figure through Dec 2012 stood at $4.0 million (up 1505.26% YoY), and the FY2012 full-year result was $4.0 million, up 1505.26% from the prior year.
- Current Taxes for Q4 2012 stood at $4.0 million, up from $247000.0 in the prior quarter.
- The five-year high for Current Taxes was $4.0 million in Q4 2012, with the low at $247000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 598.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 476.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 650.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 231.81 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.60 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 3.97 Mn |
| Dec 31, 2011 | 247,000.00 |